Literature DB >> 21157423

Eczema across the world: the missing piece of the jigsaw revealed.

Hywel C Williams1.   

Abstract

Cleverly using records obtained from the 2003 National Survey of Children's Health (NSCH), Shaw et al. provide a pioneering glimpse into the burden of eczema across the United States. Using parental reports of a doctor's diagnosis of eczema in the past 12 months, the authors show that eczema affects around 9-18% of children age 17 and under. The study confirms reported associations such as living in metropolitan areas, higher household education level, and black ethnicity. Novel findings include the demonstration of higher eczema prevalence along the East Coast. The study correlates well with previous reports and may help point to environmental factors that contribute to the development of eczema.

Entities:  

Mesh:

Year:  2011        PMID: 21157423     DOI: 10.1038/jid.2010.333

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Dermatoses in Latin American Immigrant Children Seen in a Universitary Hospital of Spain.

Authors:  María Pérez-Crespo; José Manuel Ramos-Rincón; María Pilar Albares-Tendero; Isabel Betlloch-Mas
Journal:  J Immigr Minor Health       Date:  2016-02

Review 2.  Atopic dermatitis in adolescence.

Authors:  Giampaolo Ricci; Federica Bellini; Arianna Dondi; Annalisa Patrizi; Andrea Pession
Journal:  Dermatol Reports       Date:  2011-12-19

3.  Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) cohort, 2004-2012.

Authors:  Michael R Sargen; Ole Hoffstad; David J Margolis
Journal:  J Invest Dermatol       Date:  2013-06-17       Impact factor: 8.551

4.  Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.

Authors:  Chinedu Nwokoro; Hitesh Pandya; Stephen Turner; Sandra Eldridge; Christopher J Griffiths; Tom Vulliamy; David Price; Marek Sanak; John W Holloway; Rossa Brugha; Lee Koh; Iain Dickson; Clare Rutterford; Jonathan Grigg
Journal:  Lancet Respir Med       Date:  2014-09-08       Impact factor: 30.700

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.